Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Nephrology
Pediatric Hematology
Questions discussed in this category
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
Are there specific guidelines for managing this patient population?
1 Answer available
For patients with suspected complement-mediated TMA, are there specific clinical or laboratory parameters that can help guide the decision for starting empirical treatment (e.g., eculizumab) while awaiting the results of complement testing?
1 Answer available
How do you dose apixaban in patients with CrCl <30 mL/minute?
1 Answer available
Do you consider starting hydroxyurea in a patient with hemoglobin S-beta thalassemia with chronic kidney disease secondary to FSGS?
No transfusion dependence but has hemoglobin in the 8-9 g/dl range.
1 Answer available
Do you hold IV iron in the setting of active infection?
1 Answer available
Is there any role for iron chelation in a patient with iatrogenic transfusion-induced iron overload such as in patients with end-stage kidney or liver disease?
Does transplant eligibility make a difference for management?
1 Answer available
In which patients with atypical HUS would you consider eculizumab discontinuation?
Given the high cost of eculizumab, are there patient characteristics that inform which patients, if any, should be on indefinite therapy versus a time...
2 Answers available
20638
17219
12910
17407
13902
10220
8924
Papers discussed in this category
Blood, 2017-07-20
Eculizumab cessation in atypical hemolytic uremic syndrome.
Clin J Am Soc Nephrol, 2016 Oct 31
Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.
Blood, 2020 Dec 03
Eculizumab discontinuation in children and adults with atypical haemolytic uremic syndrome: a prospective multicentric study.
Circulation, 2022 Nov 06
A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study.
Circulation, 2022 Nov 06
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 2021 Dec 06
Antithrombotic Management in Adult Kidney Transplantation: A European Survey Study.
Related Topics in Nephrology
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Genitourinary Cancers
Melanoma/Skin Cancer
Pediatric Hematology/Oncology
Prostate Cancer
Medical Oncology
Endocrine Tumors